Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State

NCT02058576 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Urologic Diseases

Interventions

DRUG: Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg
DRUG: Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule

Sponsor

GlaxoSmithKline